WuXi PharmaTech (WX) Earnings

WuXi PharmaTech (WX) earnings seem quite stellar on first glance - I am assuming the analysts expectations are non GAAP since we live in a non GAAP world (which is a whole issue onto itself) but I digress. $0.14 EPS was consensus, with a range of 8 analysts of $0.08 to $0.19 - I only point that out because this is a young company with a short track record and a bevy of analysts who are having trouble coming to a consensus.

They appear to have done a $0.21 quarter... and the market yawns if last nights after hours action signifies anything. If this was an American contract research organization posting a beat of that significance (50% over consensus) I assume it would be up 15-20%. Oh well, the beat goes on. Or is it (our) beating goes on. We even have the right sector (health care) on this one, but apparently the wrong country.

• Net revenues for the second quart